http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2012006485-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_751562df05f1831baef905641425c407
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d2499dd49f5ed9b6dde950ee62f48c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871f1cfafd87bb05f2fdefb99fc79188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64fd8c146d2048b7f8c4837dcdfc8222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbf309acbe37d48adbf0c0adc8248635
publicationDate 2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2012006485-A
titleOfInvention PIRIDINON HYDROXYLICOPENTIL CARBOXAMIDS: INHIBITORS OF HIV INTEGRESS WITH THERAPEUTIC APPLICATIONS.
abstract New cyclopentyl pyridinon diketocarboxamides substituted with oxy, chiral and aquirals, and their derivatives and methods for their preparations are described. The compounds include tautomers, regioisomers and geometric isomers. These complex carboxamides are designed as inhibitors of HIV replication through inhibition of HIV integrase. The compounds are useful in the prevention or treatment of HIV infection and in the treatment of AIDS and the AIDS Related Complex (ARC), either as the compounds, or as pharmaceutically acceptable salts, with pharmaceutically acceptable carriers, used alone or in combination with antivirals, immunomodulators, antibiotics, vaccines and other therapeutic agents, especially other anti-HIV compounds (including other anti-HIV integrase agents), which can be used to create combined anti-HIV preparations . Methods to treat AIDS and ARC and methods to treat or prevent HIV infection are also described.
priorityDate 2009-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448355367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157736807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67257904
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100862683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410527804

Total number of triples: 29.